Search images on Google      Product Monograph

Active Ingredients:

• trastuzumab deruxtecan, 100 MG/VIAL

DIN: 02514400

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC  –  official site

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FD - (ATC, WHO)
• L01FD04 - TRASTUZUMAB DERUXTECAN (WHO)

 

External Links for Enhertu:

Search on Google

• Enhertu side effects
• Enhertu dosage
• trastuzumab deruxtecan side effects
• trastuzumab deruxtecan dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find enhertu photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.